Newsletters
The Capitalist Newsletter – November 30, 2016
TRUMP NOMINATES TOM PRICE AS SECRETARY OF HEALTH AND HUMAN SERVICES; SIGNALS END OF OBAMACARE |
|
Winners & Losers – Genetic Technologies Ltd. (GENE) Jumps UP (63.73%) After Announcing Licensing Agreement with The University of Melbourne – Nivalis Therapeutics, Inc. (NVLS) Plummets DOWN (58.88%) After Cystic Fibrosis Drug Study Fails
Most Talked About CombiMatrix Corp. (CBMX) a Hot Topic as the Vast Majority Consider the Stock a Strong Buy Following CBMX Announcing that its Pre-Implantation Genetic Screening Test Received Conditional Approval in New York
The TIP Sheets – Tuesday, November 29th – The Allstate Corp. (ALL) Dips DOWN (3.35%) After Announcing the Company is Purchasing Squaretrade, Seller of Warranties for Electronic Devices. With Allstate Looking to Expand into Consumer Goods,Expect Shares to Bounce Back UP
Unusual Volume
– Amicus Therapeutics, Inc. (FOLD) Falls DOWN (21.75%) on 12.3m Shares Traded After Announcing Another Drug Trial Will be Necessary Before the Company Can File for FDA Approval of its Fabry Disease Drug. Look For Shares to Continue DOWN |
